Iqvia Holdings Inc.
IQV · NYSE · United States · Health Care · Pharma / Biotech / Life Sci
- Coverage
- FY2016–FY2025
- History
- 10 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- December
- Last updated
- Feb 2026
Headline figures
Iqvia Holdings Inc. at a glance
In FY2025, Iqvia Holdings Inc. reported revenue of USD 16,310 mn, EBITDA of USD 3,431 mn, EBITDA margin of 21.0%.
| USD mn | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 15,405 | 16,310 | |||
| EBITDA | 3,383 | 3,431 | |||
| EBITDA margin | 22.0% | 21.0% | |||
| Free cash flow | 2,114 | 2,051 | |||
| ROIC | 10.2% | 10.1% |
The full 10-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas